# Vertex Pharmaceuticals Incorporated – FDA Inspection, Oct 16, 2014

Source: https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/97e56b9d-5cb4-4782-83df-22c75a2e5dba
Source feed: FDA_Inspections

> FDA inspection 902520 of Vertex Pharmaceuticals Incorporated, October 16, 2014. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 314. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 902520
- Company Name: Vertex Pharmaceuticals Incorporated
- Inspection Date: 2014-10-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1333028 - 2026-07-31
- [FDA Inspection 1306258 - 2026-03-03](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/bc146f43-1e81-4339-a15b-d826e903c323)
- FDA Inspection 1246447 - 2024-08-01
- [FDA Inspection 1205834 - 2023-05-04](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/4cbf0acd-6531-444b-9f0e-e38d042a7300)
- FDA Inspection 1180001 - 2022-08-19

Company: https://www.keypedia.com/companies/vertex-pharmaceuticals-incorporated/f2bc62b8-1ece-42d2-b058-39466a256c74

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
